Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Doxorubicin liposomal/paclitaxel

Dermatological disorders: 2 case reports

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Hackbarth M, Haas N, Fotopoulou C, Lichtenegger W, Sehouli J.Chemotherapy-induced dermatolgoical toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study. Supportive Care in Cancer 16: 267-273, No. 3, Mar 2008 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Doxorubicin liposomal/paclitaxel. React. Wkly. 1199, 20 (2008). https://doi.org/10.2165/00128415-200811990-00056

    Download citation

    Keywords

    • Public Health
    • Paclitaxel
    • Doxorubicin
    • Patient Outcome
    • Reaction Onset